国产精品99一区二区三_免费中文日韩_国产在线精品一区二区_日本成人手机在线

Hong Kong scientists discover deadly brain cancer mutation route

Source: Xinhua| 2018-12-03 22:09:36|Editor: Li Xia
Video PlayerClose

HONG KONG, Dec. 3 (Xinhua) -- The mutational mechanism of a rare and deadly brain cancer has been uncovered by scientists from the Hong Kong University of Science and Technology, providing new therapeutic lead to the disease.

Starting off at nerve cells around the spine and brain, lower-grade glioma (LGG) is the early form of sGBM -- one of the deadliest brain cancers. While sGBM can be treated with surgery or an oral chemotherapy drug, most of these malign tumors would mutate and return with mortality rate reaching almost 100 percent.

In their latest study made public on Monday, the team led by Wang Jiguang, assistant professor at the university's Division of Life Science and Department of Chemical and Biological Engineering, analyzed and integrated the genomic data of 188 sGBM patients, including newly collected samples from Chinese mainland and South Korean patients.

The study found that about 14 percent of the sampled sGBM patients displayed mutations in this gene.

Taking reference from this discovery, the university's collaborators, Jiang Tao and his team from Beijing Neurosurgical Institute and Beijing Tiantan Hospital, identified a drug molecule named PLB-1001 that can reach the tumors in the brain.

The molecule shows remarkable potency in selectively targeting sGBM tumors and those displaying further gene mutations.

The clinical trial of PLB-1001 on 18 recurrent patients at late cancer stage returned with a partial positive response in two patients.

After being prescribed a daily dosage ranging from 50 to 300 mg at Beijing Tiantan Hospital, the two patients experienced significant tumor shrinkage, with relieved symptoms and little side effects, lasting for more than 12 weeks.

The outcome of this clinical trial is significant in a sense that it furthers the knowledge about sGBM treatment, Wang said, adding that developing computational models on cancer evolution helps predict cancer cells' future behavior and prioritize treatment options.

Wang said more studies on PLB-1001 are needed to see if it can be used in conjunction with other drugs in achieving more persistent results.

The findings were published in scientific journal Cell on Nov. 29.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001376484241
主站蜘蛛池模板: 靖西县| 湖南省| 文登市| 宜宾县| 东台市| 都兰县| 新昌县| 怀安县| 赤城县| 德化县| 台北县| 洛宁县| 正安县| 黑山县| 衡阳县| 连山| 安泽县| 工布江达县| 泗水县| 孟津县| 龙门县| 咸丰县| 宁南县| 旬邑县| 特克斯县| 舟曲县| 赣榆县| 新河县| 陵川县| 新竹市| 金平| 兴宁市| 武夷山市| 揭阳市| 灯塔市| 鄯善县| 深泽县| 温州市| 黄陵县| 鄂尔多斯市| 葫芦岛市|